+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Ultrasound, Nuclear Medicine), By End-Use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 105 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5943940
Description Jump to:
The global vascular imaging market size is expected to reach USD 8.52 billion by 2030, registering a CAGR of 4.19% from 2024 to 2030. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging is gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Vascular Imaging Market Report Highlights

  • By type, non-invasive segment held the largest share in vascular imaging market in 2023 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2023, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Vascular Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of cancer and cardiac diseases
3.2.1.2. Favorable government initiatives
3.2.1.3. Trends of preventive healthcare and disease screening programs
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High cost of product
3.2.2.2. Increasing use of refurbished products
3.3. Vascular Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
Chapter 4. Vascular Imaging Market: Modality Estimates & Trend Analysis
4.1. Modality Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Vascular Imaging Market by Modality Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. CT
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. MRI
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Ultrasound
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Nuclear Medicine
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Vascular Imaging Market: End-Use Estimates & Trend Analysis
5.1. End-Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Vascular Imaging Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Imaging Centers
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Others
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Vascular Imaging Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Siemens Healthineers
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. GE Healthcare
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Koninklijke Philips N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Hitachi Medical Corporation.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Samsung Medison Co., Ltd.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Shimadzu Corporation
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Hologic Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Carestream Health Inc...
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America vascular imaging market, by region, 2018 - 2030 (USD Million)
Table 3 North America vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 4 North America vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 6 U.S. vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 8 Canada vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 9 Europe vascular imaging market, by region, 2018 - 2030 (USD Million)
Table 10 Europe vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 11 Europe vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 12 Germany vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 13 Germany vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 14 UK vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 15 UK vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 16 France vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 17 France vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 18 Italy vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 19 Italy vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 20 Spain vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 21 Spain vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 22 Denmark vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 23 Denmark vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 24 Sweden vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 25 Sweden vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 26 Norway vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 27 Norway vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific vascular imaging market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 30 Asia Pacific vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 31 China vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 32 China vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 33 Japan vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 34 Japan vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 35 India vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 36 India vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 37 South Korea vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 38 South Korea vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 39 Australia vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 40 Australia vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 41 Thailand vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 42 Thailand vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 43 Latin America vascular imaging market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 45 Latin America vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 46 Brazil vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 47 Brazil vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 48 Mexico vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 49 Mexico vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 50 Argentina vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 51 Argentina vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 52 MEA vascular imaging market, by region, 2018 - 2030 (USD Million)
Table 53 MEA vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 54 MEA vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 55 South Africa vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 56 South Africa vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 59 UAE vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 60 UAE vascular imaging market, by end use, 2018 - 2030 (USD Million)
Table 61 Kuwait vascular imaging market, by modality, 2018 - 2030 (USD Million)
Table 62 Kuwait vascular imaging market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Vascular imaging market: market outlook
Fig. 14 Vascular imaging competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Vascular imaging market driver impact
Fig. 20 Vascular imaging market restraint impact
Fig. 21 Vascular imaging market strategic initiatives analysis
Fig. 22 Vascular imaging market: Modality movement analysis
Fig. 23 vascular imaging market: Modality outlook and key takeaways
Fig. 24 CT market estimates and forecast, 2018 - 2030
Fig. 25 MRI estimates and forecast, 2018 - 2030
Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 27 Nuclear Medicine estimates and forecast, 2018 - 2030
Fig. 28 Vascular imaging Market: End-use movement Analysis
Fig. 29 vascular imaging market: End use movement analysis
Fig. 30 vascular imaging market: End use outlook and key takeaways
Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 32 Imaging Centers market estimates and forecasts,2018 - 2030
Fig. 33 Others market estimates and forecasts,2018 - 2030
Fig. 34 Global vascular imaging market: Regional movement analysis
Fig. 35 Global vascular imaging market: Regional outlook and key takeaways
Fig. 36 Global vascular imaging market share and leading players
Fig. 37 North America market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Asia Pacific market share and leading players
Fig. 40 Latin America market share and leading players
Fig. 41 Middle East & Africa market share and leading players
Fig. 42 North America, by country
Fig. 43 North America market estimates and forecasts, 2018 - 2030
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
Fig. 45 Canada market estimates and forecasts, 2018 - 2030
Fig. 46 Europe market estimates and forecasts, 2018 - 2030
Fig. 47 UK market estimates and forecasts, 2018 - 2030
Fig. 48 Germany market estimates and forecasts, 2018 - 2030
Fig. 49 France market estimates and forecasts, 2018 - 2030
Fig. 50 Italy market estimates and forecasts, 2018 - 2030
Fig. 51 Spain market estimates and forecasts, 2018 - 2030
Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
Fig. 54 Norway market estimates and forecasts, 2018 - 2030
Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 56 China market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 India market estimates and forecasts, 2018 - 2030
Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
Fig. 61 Australia market estimates and forecasts, 2018 - 2030
Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 69 UAE market estimates and forecasts, 2018 - 2030
Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 71 Market share of key market players- vascular imaging market

Companies Mentioned

  • Siemens Healthineers
  • Abbott Laboratories
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Hitachi Medical Corporation.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Hologic Inc.
  • Carestream Health Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages105
PublishedFebruary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 6.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.52 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Nuclear Imaging Equipment Market Size, Share & Trends Analysis Report By Modality (SPECT, PET), By Application (Cardiology, Oncology), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Nuclear Imaging Equipment Market Size, Share & Trends Analysis Report By Modality (SPECT, PET), By Application (Cardiology, Oncology), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Vascular Imaging - Global Strategic Business Report - Product Image

Vascular Imaging - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Vascular Imaging - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vascular Imaging - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Vascular Imaging Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Vascular Imaging Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Vascular Imaging Devices Market Report 2024 - Product Image

Vascular Imaging Devices Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Vascular Imaging Market

The Vascular Imaging market is a subset of the Medical Imaging industry, which uses imaging technologies to diagnose and treat medical conditions. Vascular Imaging specifically focuses on the diagnosis and treatment of diseases and disorders of the vascular system, such as aneurysms, arterial blockages, and venous malformations. It is used to detect and monitor the progression of vascular diseases, as well as to plan and guide treatments. Vascular Imaging technologies include X-ray angiography, computed tomography (CT) angiography, magnetic resonance angiography (MRA), and ultrasound. These technologies are used to create detailed images of the vascular system, allowing physicians to accurately diagnose and treat vascular diseases. Some companies in the Vascular Imaging market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.